STING agonist delivery by tumour-penetrating PEG-lipid nanodiscs primes robust anticancer immunity
<jats:title>Abstract</jats:title><jats:p>Activation of the innate immune STimulator of INterferon Genes (STING) pathway potentiates antitumour immunity, but systemic delivery of STING agonists to tumours is challenging. We conjugated STING-activating cyclic dinucleotides (CDNs) to...
Main Authors: | Dane, Eric L, Belessiotis-Richards, Alexis, Backlund, Coralie, Wang, Jianing, Hidaka, Kousuke, Milling, Lauren E, Bhagchandani, Sachin, Melo, Mariane B, Wu, Shengwei, Li, Na, Donahue, Nathan, Ni, Kaiyuan, Ma, Leyuan, Okaniwa, Masanori, Stevens, Molly M, Alexander-Katz, Alfredo, Irvine, Darrell J |
---|---|
Other Authors: | Koch Institute for Integrative Cancer Research at MIT |
Format: | Article |
Language: | English |
Published: |
Springer Science and Business Media LLC
2023
|
Online Access: | https://hdl.handle.net/1721.1/147842 |
Similar Items
-
Nanoparticulate STING agonists are potent lymph node–targeted vaccine adjuvants
by: Crespo, Monica P., et al.
Published: (2015) -
Polymeric STING pro-agonists for tumor-specific sonodynamic immunotherapy
by: Yu, Jie, et al.
Published: (2023) -
Neoadjuvant STING Activation, Extended Half-life IL2, and Checkpoint Blockade Promote Metastasis Clearance via Sustained NK-cell Activation
by: Milling, Lauren E, et al.
Published: (2023) -
Delivery of Stimulator of Interferon Genes (STING) Agonist Using Polypeptide‐Modified Dendrimer Nanoparticles in the Treatment of Melanoma
by: Dosta, Pere, et al.
Published: (2022) -
Evolution of Toll-like receptor 7/8 agonist therapeutics and their delivery approaches: From antiviral formulations to vaccine adjuvants
by: Bhagchandani, Sachin, et al.
Published: (2021)